REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Thailand targets vaccination of 19 mln people in first phase

Wed, 27th Jan 2021 10:12

(Recasts with vaccination plans)

By Panarat Thepgumpanat and Chayut Setboonsarng

BANGKOK, Jan 27 (Reuters) - Thailand is targeting the
immunisation of 19 million people against the coronavirus in a
first phase of inoculations starting on Feb. 14, the prime
minister said on Wednesday, amid criticism the government has
been slow in rolling out vaccines.

Inoculations will begin with 50,000 doses of AstraZeneca's
vaccine, Prayuth Chan-ocha said. He gave no timeline for
the first phase.

By May, Thailand will have received 150,000 doses from
AstraZeneca.

In a broadcast carried on the government's website, Prayuth
apologised for not solving COVID-19 related problems as fast as
the public had demanded.

"Blaming each other will not solve any problems," he said.

Of the 19 million to be vaccinated, 11 million would be
people aged over 60 and 6.1 million would be those with
underlying diseases, he said.

Another 1.7 million would be for medical professionals and
15,000 government workers involved in managing the virus, he
said, adding those under 18 and pregnant women would not be
vaccinated. About a fifth of Thailand's population is under 18.

The timeframe would depend on the capacity of hospitals
administering the vaccines and number of doses they receive,
head of the government's vaccine management committee, Sophon
Mekthon, told Reuters.

Thailand has altogether secured 26 million doses from
AstraZeneca to be produced by local firm Siam Biosience and 2
million doses from China's Sinovac. It has also reserved
35 million doses from AstraZeneca.

Thailand will initially import the vaccines but is expected
by June to be producing it locally, Sophon added.

Authorities say they will vaccinate 31.5 million people.

The education ministry on Wednesday said it would reopen
most schools from next week, in response to localised declines
in new coronavirus infections.

The announcement comes despite the country reporting on
Wednesday its second-highest number of new daily coronavirus
cases, with 819 infections, the majority due to mass testing in
Samut Sakhon province, the epicentre of the most recent
outbreak.

Thailand has reported 15,465 cases and 76 deaths.
(Reporting by Chayut Setboonsarng and
Panarat Thepgumpanat; Editing by Martin Petty and Angus MacSwan)

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.